Tag results:

Immune Regulation News

Fibrinogen Protects Neutrophils from the Cytotoxic Effects of Histones and Delays Neutrophil Extracellular Trap Formation Induced by Ionomycin

[Scientific Reports] Histones were rapidly lethal to neutrophils after binding to cells, but formation of fibrinogen/fibrin-histone aggregates prevented cell death.

CFTR Is a Negative Regulator of γδ T Cell IFN-γ Production and Antitumor Immunity

[Cellular & Molecular Immunology] Investigators observed that CFTR was functionally expressed on the cell surface of γδ T cells. Genetic deletion and pharmacological inhibition of CFTR both increased IFN-γ release by peripheral γδ T cells and potentiated the cytolytic activity of these cells against tumor cells both in vitro and in vivo.

Fc Gamma Receptors and Their Role in Antigen Uptake, Presentation, and T Cell Activation

[Frontiers in Immunology] Investigators cover the contribution of FcγRs to antigen-presentation with a focus on the intracellular trafficking of IgG-immune complexes and the pathways that support this function.

Macrophage Metabolic Reprogramming Presents a Therapeutic Target in Lupus Nephritis

[Proceedings of the National Academy of Sciences of the United States of America] Investigators found that human and mouse macrophages underwent a switch to glycolysis in response to IgG immune complex stimulation, mirroring macrophage metabolic changes in inflamed tissue in vivo. This metabolic reprogramming was required to generate a number of proinflammatory mediators, including IL-1β, and was dependent on mTOR and hypoxia-inducible factor-1α.

Determinants of Resident Tissue Macrophage Identity and Function

[Immunity] The authors review recent findings within this context and discuss the technological advances that are revolutionizing the study of macrophage biology.

Nanoparticle Delivery of Immunostimulatory Oligonucleotides Enhances Response to Checkpoint Inhibitor Therapeutics

[Proceedings of the National Academy of Sciences of the United States of America] Researchers found that their engineered nanoparticles carrying a CpG DNA ligand of TLR9 could suppress tumor growth in several animal models of various cancers, resulting in an abscopal effect on distant tumors, and improving responsiveness to anti-CTLA4 treatment with combinatorial effects after intratumoral administration.

Popular